These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Artificial blood--the past, present, and future (II)]. Minoshima T Kokyu To Junkan; 1982 Oct; 30(10):970-9. PubMed ID: 6760310 [No Abstract] [Full Text] [Related]
64. Blood substitutes: where do we stand today? Kjellström BT J Intern Med; 2003 May; 253(5):495-7. PubMed ID: 12702026 [No Abstract] [Full Text] [Related]
65. ["Bloodless" animal models and its significance in physiology]. Ding XC; Zhang SN Sheng Li Ke Xue Jin Zhan; 1982 Jul; 13(3):270-2. PubMed ID: 7178894 [No Abstract] [Full Text] [Related]
66. Future perspectives in blood transfusion. Waschke KF; Quintel M; Kerger H; Lenz C Acta Anaesthesiol Scand Suppl; 1996; 109():143-7. PubMed ID: 8901987 [No Abstract] [Full Text] [Related]
67. [Société de réanimation de langue française. XXIII. Consensus conference on on resuscitation and emergency medicine--thursday October 23, 2003: erythrocyte transfusion and resuscitation (excluding newborn)]. ; ; ; ; Ann Fr Anesth Reanim; 2004 Jul; 23(7):765-71. PubMed ID: 15324974 [No Abstract] [Full Text] [Related]
68. [The use of perftoran in clinical medicine]. Moroz VV; Kruylov NL; Ivanitskii GR; Kaidash AN; Onishchenko NA; Simanov VA; Vorob'ev SI Anesteziol Reanimatol; 1995; (6):12-7. PubMed ID: 8713413 [No Abstract] [Full Text] [Related]
69. [Perftoran--blood substitute with oxygen transport function]. Golubev AM Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539 [No Abstract] [Full Text] [Related]
70. Can "artificial blood' live up to public billing? Cowart VS JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595 [No Abstract] [Full Text] [Related]
71. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes. Bolin RB Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893 [TBL] [Abstract][Full Text] [Related]
72. Synthetic blood: a future alternative. Leser DR Am J Nurs; 1982 Mar; 82(3):452-5. PubMed ID: 6917693 [No Abstract] [Full Text] [Related]
73. [Artificial oxygen carriers. Alternatives to homologous blood transfusion?]. Habler O; Kleen M; Messmer K Zentralbl Chir; 1999; 124(4):260-70. PubMed ID: 10355079 [TBL] [Abstract][Full Text] [Related]
74. [Current aspects in red blood cell substitutes]. Wang Y; Pan J; Yu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [TBL] [Abstract][Full Text] [Related]
75. Immunological biocompatibility in blood substitutes. Vercellotti GM; Hammerschmidt DE Int Anesthesiol Clin; 1985; 23(1):47-62. PubMed ID: 3980107 [No Abstract] [Full Text] [Related]
76. [The use of perfluorocarbon emulsions for suppression of rejection reaction in kidney allotransplantation]. Ilgiavishute IaS; Zhukauskas GIu; Dapshis KL; Onishchenko NA Khirurgiia (Mosk); 1993 May; (5):16-8. PubMed ID: 8089979 [TBL] [Abstract][Full Text] [Related]